Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CDA | P32320 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.31 |
| ▸ | AXL | P30530 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13110102 | 0.78 | CDA (0.33) | HSD17B10CDAMAPTALDH1A1SMPD3 | |
| SCHEMBL22297522 | 0.72 | ALDH1A1 (0.33) | HSD17B10CDAMAPTALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL11735192 | 0.71 | SMPD3 (0.34) | SMPD3 | |
| SCHEMBL9447537 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL3807552 | 0.65 | BRD4 (0.43) | MAPTALDH1A1HTTLMNAHPGD | |
| SCHEMBL7055387 | 0.65 | — | — | |
| SCHEMBL7889176 | 0.65 | — | — | |
| SCHEMBL724529 | 0.65 | — | — | |
| SCHEMBL8225115 | 0.65 | — | — | |
| SCHEMBL15898285 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004016271-A1 | PYRIMIDONES AS ANTIVIRAL AGENTS | AXXIMA PHARMACEUTICALS AG (DE) | 2004-02-26 | — | — | WO | claimed |
| US-9796676-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2016-09-01 | — | — | US | disclosed |
| US-9357781-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| WO-2014179785-A1 | IMPROVED HONEYBEE REPELLENTS AND USES THEREOF | INSCENT, INC. (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2014-11-06 | — | — | US | disclosed |
| WO-2013163454-A2 | PSYLLID ATTRACTANTS AND THEIR USES | INSCENT, INC. (US) | 2013-10-31 | — | — | WO | disclosed |
| WO-2004016271-A1 | PYRIMIDONES AS ANTIVIRAL AGENTS | AXXIMA PHARMACEUTICALS AG (DE) | 2004-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | HSD17B10 310/4885CDA 4781/4885MAPT 1877/4885 |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | HSD17B10 310/4885CDA 4781/4885MAPT 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.